Peptide purity testing requires several distinct questions: what the material is, which impurities a method detects, how much target peptide is present, and which additional attributes were measured. HPLC, LC-MS, quantitative content assays and specialized tests provide complementary evidence. A single purity percentage cannot answer all of those questions or authenticate every vial.
- Separate identity, chromatographic purity, content and other material attributes.
- Read each result with its method, units and reporting basis.
- Match the report to the specific compound and lot.
- Treat missing tests as unreported, not as passing results.
- Use orthogonal evidence and documented method suitability.
A map of analytical questions
| Question | Possible analytical evidence | Important limitation |
|---|---|---|
| What is the material? | Suitable identity data, often including MS and structural context | An expected mass match may not resolve all structural alternatives |
| What does chromatography separate and detect? | Chromatogram, integration and method details | Area percentage is conditional on detector response and separation |
| How much target peptide is present? | A suitable quantitative assay or content assignment | The analyte and denominator must be defined |
| What water or counterions contribute? | Separate fit-for-purpose constituent measurements | A peptide chromatogram may not account for these mass contributions |
| Was endotoxin or bioburden tested? | The corresponding test and its reporting units | Neither is established by ordinary HPLC purity |
| Which material does the report describe? | Lot, sample and report identifiers | A report for another lot does not answer this question |
How HPLC purity is calculated and limited
A chromatographic method separates detected components over time. Area purity usually expresses the principal assigned peak’s integrated area relative to a stated sum of areas. That result depends on the detector, wavelength where relevant, separation, sample preparation and integration rules. It is not automatically a mass percentage of the powder.
Co-elution can make more than one component appear within a single peak. Different compounds can also produce different detector responses. A high area result is useful evidence within the method’s scope; it does not independently establish identity, net content, sterility or the absence of every impurity. The HPLC and MS comparison explains the complementary roles.
How LC-MS supports identity
MS measures ions by mass-to-charge ratio. A peptide may generate several charge states or adduct-related signals, so the observed value must be interpreted alongside an expected structure and ion assignment. The expected neutral molecular mass is not interchangeable with every observed m/z value.
Mass evidence can support identity but may leave sequence isomers, stereochemical differences or other alternatives unresolved. The report should state what conclusion the method supports. A spectrum, sample identifier and assignment are more useful than an unlabeled mass number. The analytical question determines whether additional characterization is necessary.
Net content, water and counterions
A weighed powder may include the peptide, salt-associated constituents, water and other material. Content assays address the amount of a defined analyte on a stated basis. Chromatographic area and content values should not be combined through automatic multiplication when their corrections overlap.
Read the net peptide content and gross-weight guide for an illustrative mass balance. TFA, acetate or other stated counterions should be characterized with suitable methods where relevant. Karl Fischer water measurements answer a different question from identity or chromatographic purity. Neither result can substitute for the other.
Synthesis impurities and stability-related changes
Potential peptide-related impurities include sequence deletions or truncations, incompletely removed groups and modified forms. Their relevance depends on the synthesis and purification history. Stereochemical differences can also be difficult to establish through mass alone. A method must be suitable for the impurities that matter to the stated analytical question.
Storage-related oxidation and deamidation present a different set of questions. A shifted chromatographic peak or plausible mass increment is an observation that still needs assignment. See oxidation and deamidation interpretation and lyophilized storage variables. This library does not prescribe a universal shelf life or a reconstitution protocol.
Endotoxin, bioburden and sterility are separate attributes
Endotoxin testing, microbial counts and sterility testing have different targets and reporting conventions. A standard peptide chromatogram or expected mass result does not establish any of them. Where a record includes an endotoxin result, read the method, units, sample basis and applicable controls rather than converting it into a general safety claim.
Likewise, absence of a reported test should be recorded as unreported. It is not a zero result. Whether a particular test package is appropriate depends on a laboratory’s defined analytical requirements. This guide discusses documentation and does not assert that every SRL lot has every test listed here.
Third-party versus in-house testing
The laboratory’s relationship to the supplier is useful context, but it does not replace method or sample review. For either source, check who submitted the sample, which lot or sample identifier was tested, what method was used and what the result supports. Independence and technical adequacy are related but separate questions.
Where direct verification is available, use the issuing laboratory’s independently located official channel and the report identifier. Confirm the scope of any verification response. A genuine report can still be mismatched to the material under evaluation. The COA verification guide and lot-traceability guide provide the document-control context.
Use the printable COA review worksheet to keep the report identifiers, identity evidence, chromatographic purity basis and separately measured attributes in one record. The COA reading guide explains the fields and how to mark information that is not reported or not verified.
An original report-review checklist
- Identify the exact compound, chemical form, sample and lot.
- Separate identity evidence from chromatographic area purity.
- Record quantitative content only on the basis actually reported.
- List water, counterion, solvent or microbiological tests only if present.
- Inspect the available chromatogram, spectrum and method context.
- Resolve conflicts among the label, listing and laboratory record.
- Keep unresolved attributes visible and request the relevant documentation.
This checklist is a way to organize evidence, not a certification or pass/fail standard. No universal percentage threshold establishes that a material fits every analytical purpose. ICH Q2(R2) is useful background on analytical validation principles for regulated products; it does not certify SRL materials or create a specification for this catalog.
Explore the documentation and literature library
- BPC-157 laboratory-model review
- GHK-Cu analytical interpretation
- Lyophilized peptide storage
- TB-500 and thymosin beta 4 identity
- NAD+ analytical documentation
- Net peptide content versus gross weight
- CJC-1295 terminology and identity
- Peptide oxidation and deamidation
- How to read and verify a peptide COA
- HPLC versus mass spectrometry
- GLOW versus KLOW composition and blend COAs
- View lot-level testing reports
Frequently asked questions
Does 99% HPLC purity establish identity and net content?
No. Identity, relative chromatographic area and quantitative content are different analytical questions.
Is third-party testing sufficient without lot matching?
No. Even an authentic independent report must be connected to the material under evaluation.
Does a peptide purity result establish sterility or endotoxin status?
No. Those attributes need their own suitable tests and cannot be inferred from HPLC or MS alone.
Can a matching molecular mass resolve every structural alternative?
No. Some isomeric or stereochemical differences require additional characterization.
Foundational education and procurement guides
These existing field guides provide the basic terminology and document-control context for the analytical articles above.
- What Are Peptides? A Plain-English Guide
- Where Do Peptides Come From? Nature, Synthesis, and the Lab
- Peptides vs. Proteins vs. Amino Acids
- Why Are Peptides Popular Again?
- How Peptides Send Signals in Biology
- How to Read Peptide Headlines Without Getting Misled
- Why Lot Traceability Matters for Research Materials
- How to Choose a U.S. Research Peptide Supplier: A Documentation Checklist
- Research Peptide 10-Packs: A Laboratory Procurement Checklist
Continue with the documentation guides
Sources and scope
Selected primary research and analytical references. These references support the specific model or measurement discussed; they do not certify SRL materials or establish human outcomes.
- FDA, Q2(R2) Validation of Analytical Procedures (2024), analytical-validation framework for regulated products.
- Primary sublancin purity-assignment study, illustrating mass-balance and amino-acid-analysis approaches.
- Primary capillary-electrophoretic measurement of acetic acid and trifluoroacetic acid in synthetic peptides.
- Primary HILIC-MS investigation of peptide modifications.
Prepared by Stealth Research Labs. Source check: October 1, 2026.
Strictly for laboratory research use only. Not for human or animal consumption. No dosing, administration, or protocol guidance.



[…] The complete guide to peptide purity testing […]
[…] The complete guide to peptide purity testing […]
[…] The complete guide to peptide purity testing […]
[…] The complete guide to peptide purity testing […]
[…] The complete guide to peptide purity testing […]
[…] The complete guide to peptide purity testing […]
[…] The complete guide to peptide purity testing […]
[…] Peptide purity testing […]
[…] The complete guide to peptide purity testing […]